Tradestie Institutional Equity Comparison Engine

BZFD vs AARD โ€” Head-to-Head Terminal

6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.

Market Close: 2026-11-20 Buy Verdict Report Ask Alpha

Pillar 1 Executive Scorecard & Category Winner Tally

AARD Overall Edge

AARD Captures Institutional Edge (2โ€“1 Pillars ยท 4โ€“4 Matrix Metrics)

Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Aardvark Therapeutics, Inc. Common Stock (AARD) driven by superior Growth & Margin, Options & Structure while BZFD counters with relative strength in Momentum & Technical. Fundamentally, BZFD trades at N/M Forward P/E with -17.7% operating margin (-43.8% YoY revenue) versus AARD at N/M Forward P/E and 0.0% operating margin (+0.0% YoY). In options structure, BZFD sits in BREAKDOWN (50th %ile IV; Dealer Gamma Walls on Pro) against AARD sits in UNCLASSIFIED (26th %ile IV; Dealer Gamma Walls on Pro).

Valuation Winner Tie
BZFD N/M vs AARD N/M Fwd P/E
Growth & Margin Winner AARD
Op Margin -17.7% vs 0.0% ยท YoY -43.8% vs +0.0%
Momentum & Technical Winner BZFD
1Y -60.0% vs -91.2% ยท 52W Pos 2% vs 0%
Options & Structure Winner AARD
BREAKDOWN (50th %ile IV) vs UNCLASSIFIED (26th %ile IV)
BZFD NASDAQ
BuzzFeed, Inc. Class A Common Stock
Communications Services, Nec
$0.38
+2.79% 1D
Market Cap $38.1M
1M Return -61.31%
1Y Return -60.01%
Forward P/E N/M
Unified AI Score
51.3 / 100 HOLD
Tech 55.0 Fund 52.0 Flow 60.0 Mom 55.0
AARD NASDAQ
Aardvark Therapeutics, Inc. Common Stock
Pharmaceutical Preparations
$0.92
-7.74% 1D
Market Cap $21.9M
1M Return -76.64%
1Y Return -91.18%
Forward P/E N/M
Unified AI Score
45.9 / 100 HOLD
Tech 35.0 Fund 54.0 Flow 68.0 Mom 59.0

Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)

1Y Indexed Return: BZFD -60.01% AARD -91.18% Spread: +31.17 pp (BZFD Lead)

Pillar 3 Operating Profitability Benchmark (Trailing 12-Month)

Split-Invariant Revenue ($B) & Operating Margin (%)
BZFD TTM Op. Margin: -17.7% AARD TTM Op. Margin: 0.0%
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on BZFD vs AARD. Trailing 12-month operating profitability (BZFD -17.7% vs AARD 0.0%) and valuation multiples (BZFD N/M vs AARD N/M Forward P/E) are benchmarked directly in Pillar 4 below.

Pillar 4 Head-to-Head Fundamental & Valuation Matrix

Matrix Tally: BZFD (4) vs AARD (4)
Institutional Metric BZFD AARD Criterion Row Winner
Market Capitalization Scale $38.1M $21.9M Larger Scale BZFD
Trailing P/E Ratio Valuation N/M N/M Lower Multiple Tie
Forward P/E Ratio Valuation N/M N/M Lower Multiple Tie
Revenue Growth (YoY) Growth -43.8% +0.0% Higher Growth AARD
Operating Margin (TTM) Profitability -17.7% 0.0% Higher Margin AARD
Net Profit Margin Profitability -48.0% 0.0% Higher Margin AARD
Return on Equity (ROE) Capital Efficiency -123.0% -66.0% Higher ROE AARD
52-Week Range Position Momentum 2% ($0โ€“$2) 0% ($1โ€“$17) Stronger Trend BZFD
Beta / 30D Volatility Risk Regime 2.52ฮฒ ยท 192% Vol 3.84ฮฒ ยท 284% Vol Lower Realized Risk BZFD
Unified Institutional Score Composite Signal 51.3 / 100 (HOLD) 45.9 / 100 (HOLD) Higher Composite BZFD

Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor

Full BZFD vs AARD Buy Guide
BZFD BREAKDOWN
126d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile 50th %ile
IV Regime Balanced (25thโ€“60th %ile)
Live BZFD Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →
AARD UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile 26th %ile
IV Regime Balanced (25thโ€“60th %ile)
Live AARD Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →

Pillar 6 90-Day Technical & R&D Innovation Disclosures

Corporate R&D & Foundry Tracker
Neither BZFD nor AARD registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.